Navigation Links
Soligenix Receives $574,000 in Non-Dilutive Financing from New Jersey's Technology Business Tax Certificate Transfer Program
Date:1/26/2012

PRINCETON, N.J., Jan. 26, 2012 /PRNewswire/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a development stage biopharmaceutical company, announced today that it has recently received approximately $574,000, net of transaction costs, in non-dilutive financing via the State of New Jersey's Technology Business Tax Certificate Transfer Program (the Program). 

This Program enables approved, unprofitable biotechnology businesses to sell their unused Net Operating Loss Carryovers (NOLs) and unused Research and Development (R&D) Tax Credits for at least 80% of the value of the tax benefits to unaffiliated, profitable corporate taxpayers in the State of New Jersey. This allows biotechnology businesses with NOLs to turn their tax losses and credits into cash proceeds to fund more R&D, buy equipment and/or facilities, or cover other allowable expenditures. The New Jersey Economic Development Authority (NJEDA) determines eligibility for the Program, the New Jersey Division of Taxation determines the value of the available tax benefits (NOLs and R&D Tax Credits), and the New Jersey Commission on Science and Technology evaluates the technology and its viability. The state of New Jersey was the originator of this Program and the first state to implement and fund it.

"As we are always looking for non-dilutive ways to fund our company, we are once again very pleased with NJEDA's decision to approve our application in this year's program," stated Christopher J. Schaber, PhD, President and CEO of Soligenix. "This NOL funding increases our cash position to about $6.2 million or roughly $0.028 cents per common share outstanding with no debt or preferred stock outstanding.  We expect this cash will last us until the third quarter of 2013. We are very thankful for New Jersey's continued support of its biotechnology industry."


'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Soligenix Initiates Next Generation Anthrax Vaccine Development Program Under Agreement With Harvard University
2. Soligenix Reports Third Quarter 2011 Financial Results
3. Soligenix Announces Formation of Pediatric Crohns Disease Medical Advisory Board
4. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBecĀ® Study in Acute GI GVHD
5. Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments
6. Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBecĀ® in Europe
7. Soligenix Announces Appointment of Jerome Zeldis, MD, PhD and Keith Brownlie, CPA to its Board of Directors
8. Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
9. Soligenix to Present at 13th Annual BIO CEO & Investor Conference
10. Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
11. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Kentucky blocked the sale of ...
(Date:8/20/2014)...  The National Association of Drug Diversion Investigators ... the real-time, pseudoephedrine (PSE) blocking system in Missouri. The ... (NPLEx), automatically blocks unlawful pseudoephedrine sales and helps ... make arrests. Data released by NPLEx shows electronic ... the sale of more than 19,030 boxes of medicine ...
(Date:8/20/2014)... -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today ... - FBR 1 st Annual Healthcare Conference ... on Wednesday, September 3 rd - Citi,s 9 ... on Thursday, September 4 th In ... of America Merrill Lynch Global Healthcare Conference at the Bank ...
Breaking Medicine Technology:Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2PTC Therapeutics to Participate at Upcoming Investor Conferences 2
... , MINNETONKA, Minn. , July 14 ... a leading provider of world-class devices and therapies for both ... prospective, multi-center study on their market leading MiniArc Single-Incision Sling ... concludes that MiniArc efficacy rates for negative cough stress test ...
... CINCINNATI , July 14 Kendle (Nasdaq: KNDL ) announced today ... Wednesday, Aug. 4, 2010 . The Company will host a telephone conference call and simultaneous ... question and answer session will follow. , , ... , , , ...
Cached Medicine Technology:12-Month Study Reports 90% Success Rate for AMS' MiniArc Single-Incision Sling 212-Month Study Reports 90% Success Rate for AMS' MiniArc Single-Incision Sling 3Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast 2Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast 3
(Date:8/21/2014)... According to a new market report published by ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 ... at USD 1,531.2 million in 2013 and is expected ... to 2019, to reach an estimated value of USD ... market is witnessing significant growth due to increasing R&D ...
(Date:8/21/2014)... HealthDay Reporter THURSDAY, Aug. 21, 2014 ... sex with a regular partner, straight women still lag ... Using surveys of single people, the Kinsey Institute research suggests ... percent of the time during sex, while lesbians do so ... achieving orgasm during about 63 percent of sexual encounters. ...
(Date:8/21/2014)... do not protest being overcompensated, even when there ... Brains and Behavior Program have found. , This ... previously believed about the inequity of others, researchers ... Brain Connectivity . These findings suggest humans, ... indicating the interest humans show in others, outcomes ...
(Date:8/21/2014)... New York (PRWEB) August 21, 2014 ... Market Research "Enteral Feeding Devices Market (Enteral Feeding Tubes, ... Syringes) - Global Industry Analysis, Size, Share, Growth, Trends ... market was valued at USD 2.0 billion in 2012 ... USD 3.1 billion in 2019growing at a CAGR of ...
(Date:8/21/2014)... A mindfulness-based therapy for depression has the added ... see their family doctors, according to a new study ... and the Institute for Clinical Evaluative Sciences (ICES). ... who received mindfulness-based cognitive therapy showed a significant reduction ... compared with those who received other types of group ...
Breaking Medicine News(10 mins):Health News:Global Microfluidic Device System Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Global Microfluidic Device System Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Study: Men, Lesbians More Likely to Have Orgasms 2Health News:Study: Men, Lesbians More Likely to Have Orgasms 3Health News:Influenced by self-interest, humans less concerned about inequity to others 2Health News:Influenced by self-interest, humans less concerned about inequity to others 3Health News:Enteral Feeding Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Enteral Feeding Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Enteral Feeding Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Mindfulness-based depression therapy reduces health care visits 2
... prostate specific antigen levels than men of normal weight. // ... not be as good at identifying early prostate cancer in ... evidence of prostate cancer. Results showed PSA levels declined as ... and throughout all races. A study done in 2003 showed ...
... not be the only thing diabetics need to do ... // say researchers based on findings of a recent ... blood pressure, is found to exacerbate the condition. ... markedly decrease the risk of neuropathy, however they also ...
... use of alternative or complementary therapies have increased over ... using // at least one form of alternative medicine. ... yoga, hypnosis, acupuncture, chiropractic care, and high-dose vitamins. ... own survey taken in 1997 to the National Health ...
... more folate are less likely to develop high blood pressure ... For the study researchers analyzed data from two large ... gave the women questionnaires, which asked about their folate and ... blood pressure at the start of the study. It was ...
... follow a heart-healthy diet and weight-loss regimen may get ... HDL (high-density lipoproteins or "good" cholesterol) levels, according to ... than 76 with low HDL and known coronary artery ... diet and lost weight. However, results showed those who ...
... sex hormones could be responsible for some of the ... ,After measuring levels of five different sex hormones in ... to those found in healthy people. All the MS ... and brain damage characteristic of the disease. ,Results ...
Cached Medicine News:
Redesigning the World's Oxygen Therapy One Device at a Time. , ,Everything you like about our OXYMATIC 400 Series conservers, only better!...
... Accutrol is similar in design to the ... incorporates a temperature probe at the tip ... can accurately determine the patient's core body ... accuracy comparable to a pulmonary artery catheter ...
... Ultra Micro Shafts For Insertion Through ... For Light-Weight ... ,Curved Shafts For A More Comfortable Approach., ... ,Protective Cap Supplied For Protection Of Jaws ...
The New Easy-To-Use Disposable Diamond Knife Cleaning System Can Remove Even Baked-On Debris In Seconds. It Is Much More Effective Than Steam Or Blocks Of Styrofoam, Much Safer For Employees As Wel...
Medicine Products: